Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Guangchao Pan"'
Autor:
Jinshui Tan, Mengya Zhong, Yanyan Hu, Guangchao Pan, Jingwei Yao, Yuanfang Tang, Hongpeng Duan, Yuelong Jiang, Weihang Shan, Jiaqi Lin, Yating Liu, Jiewen Huang, Huijian Zheng, Yong Zhou, Guo Fu, Zhifeng Li, Bing Xu, Jie Zha
Publikováno v:
Discover Oncology, Vol 14, Iss 1, Pp 1-15 (2023)
Abstract Refractory or relapsed (R/R) AML is the most challenging form of AML to treat. Due to frequent genetic mutations, therapy alternatives are limited. Here, we identified the role of ritanserin and its target DGKα in AML. Several AML cell line
Externí odkaz:
https://doaj.org/article/ed795b3fcb3644ed9cb15069fa02179c
Publikováno v:
Energy Geoscience, Vol 2, Iss 1, Pp 73-82 (2021)
The Leidong depression is one of the secondary tectonic units and the least explored part of the Beibu Gulf Basin, northern South China Sea. Exploration activities in the basin reveal that the Middle Eocene deposition was controlled by NE-SW-striking
Externí odkaz:
https://doaj.org/article/f705a4e722704dafbd6433ef793502b1
Autor:
Mengya Zhong, Jinshui Tan, Guangchao Pan, Yuelong Jiang, Hui Zhou, Qian Lai, Qinwei Chen, Liyuan Fan, Manman Deng, Bing Xu, Jie Zha
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
The key factors leading to transformed follicular lymphoma (t-FL) include the aberrations of epigenetic modifiers as early and driving events, especially mutations in the gene encoding for histone acetyltransferase. Therefore, reversal of this phenom
Externí odkaz:
https://doaj.org/article/3d713885de444a33b83a276132d8180e
Autor:
Yuanfang Tang, Mengya Zhong, Guangchao Pan, Jinshui Tan, Chendi Xie, Yuelong Jiang, Jingwei Yao, Weihang Shan, Jiaqi Lin, Jiewen Huang, Yating Liu, Zhifeng Li, Bing Xu, Jie Zha
Publikováno v:
Pharmaceuticals, Vol 16, Iss 1, p 15 (2022)
Transformed follicular lymphoma (t-FL), for which there is no efficient treatment strategy, has a rapid progression, treatment resistance, and poor prognosis, which are the main reasons for FL treatment failure. In this study, we identified a promisi
Externí odkaz:
https://doaj.org/article/40f2f2cd18014b5ab8bc4a9c0019fd00
Autor:
Jie Zha, Mengya Zhong, Guangchao Pan, Qinwei Chen, Yuelong Jiang, Qian Lai, Jinshui Tan, Hui Zhou, Hua Wu, Bing Xu
Publikováno v:
Gene. 856:147110
Optimizing prognostic stratification of patients with cytogenetic normal acute myeloid leukemia (CN-AML), a highly heterogeneous subgroup in AML, appears to be important to improve its treatment and clinical outcome. Here, we report a potential role
Publikováno v:
Energy Geoscience, Vol 2, Iss 1, Pp 73-82 (2021)
The Leidong depression is one of the secondary tectonic units and the least explored part of the Beibu Gulf Basin, northern South China Sea. Exploration activities in the basin reveal that the Middle Eocene deposition was controlled by NE-SW-striking
Publikováno v:
Blood. 140:11566-11567
Autor:
Hui, Zhou, Yuelong, Jiang, Yuetin, Huang, Mengya, Zhong, Dongmei, Qin, Chendi, Xie, Guangchao, Pan, Jinshui, Tan, Manman, Deng, Haijun, Zhao, Yong, Zhou, Yuanfang, Tang, Qian, Lai, Zhihong, Fang, Yiming, Luo, Yirong, Jiang, Bing, Xu, Jie, Zha
Publikováno v:
Cancer Letters. 554:215997
Treatment of acute myeloid leukemia (AML) with chemotherapeutic agents fails to eliminate leukemia stem cells (LSC),and thus patients remain at high risk for relapse. Therefore, the identification of agents that target LSC is an important considera
Publikováno v:
Analytica chimica acta. 1159
In this work, for the first time, a 3D printed two-in-one on-capillary detector, combining contactless conductometric detection (C4D) and photometric detection (PD), is fabricated for capillary electrophoresis (CE). The C4D Faraday shield (FS) is pri
Autor:
Qinwei Chen, Mengya Zhong, Yuelong Jiang, Bing Xu, Hui Zhou, Guangchao Pan, Jinshui Tan, Qian Lai, Fusheng Lin, Manman Deng, Jie Zha
Publikováno v:
Journal of Personalized Medicine
Volume 11
Issue 10
Journal of Personalized Medicine, Vol 11, Iss 977, p 977 (2021)
Volume 11
Issue 10
Journal of Personalized Medicine, Vol 11, Iss 977, p 977 (2021)
T-cell acute lymphoblastic leukemia (T-ALL) shows poor clinical outcome and has limited therapeutic options, indicating that new treatment approaches for this disease are urgently required. Our previous study demonstrated that apatinib, an orally sel